Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return.
Scheurer
Mark A
MA
Medical University of South Carolina, Charleston, USA. scheure@musc.edu
Bradley
Scott M
SM
Atz
Andrew M
AM
D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology*; D007231:Infant, Newborn; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy* / Q000503:physiopathology*; D011668:Pulmonary Veno-Occlusive Disease / Q000503:physiopathology* / Q000601:surgery*; D014654:Vascular Patency / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014667:Vasopressins / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D014667:Vasopressins